Attached files

file filename
10-Q - AMERICAN GENE ENGINEER CORPs32017010q.htm
EX-32.2 - EXHIBIT 32.2 - AMERICAN GENE ENGINEER CORPex32_2.htm
EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORPex31_2.htm
EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORPex31_1.htm
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of American Gene Engineer Corp. (the "Company") on Form 10-Q for the quarter ended January 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ming Lin, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 22, 2017
 
/s/ Ming Lin
 
Ming Lin
Principal Executive Officer